Latest glioblastoma multiforme Stories
-- TRXE-009 distinguished by ability to kill chemo-resistant adult and paediatric brain cancer cells SYDNEY, April 17, 2015 /PRNewswire/ -- US-Australian drug discovery company, Novogen, today
CALGARY, April 17, 2015 /PRNewswire/ - Oncolytics Biotech Inc.
DETROIT, April 13, 2015 /PRNewswire/ -- The 2015 Henry Ford Brain Tumor Symposium takes place 8 a.m. - 5 p.m.
Scientists have discovered a small RNA molecule known as miR-182 that can curb cancer-causing genes in mice with a deadly and incurable kind of brain tumor, glioblastoma mulitforme (GBM), according to a new study published in the journal Genes & Development.
LONDON, April 1, 2015 /PRNewswire/ -- SummaryGBI Research, the leading business intelligence provider, has released its latest research, "Glioblastoma Multiforme Therapeutics
Patients Too Sick for Enrollment in Phase III Trial for Newly Diagnosed GBM BETHESDA, Md., March 27, 2015 /PRNewswire/ -- Northwest Biotherapeutics, Inc.
NEW YORK, March 25, 2015 /PRNewswire/ -- The fight to treat cancer and eradicate tumors will likely benefit from a new set of treatments if early development phases continue to show promise, according
The co-chairs announce the Northwestern Brain Tumor Institute Minds Matter 2015 Fundraising Gala for May 1, 2015 CHICAGO, March 24, 2015 /PRNewswire-USNewswire/ -- One day in 2009,
BETHESDA, Md., March 24, 2015 /PRNewswire/ -- Northwest Biotherapeutics, Inc. (NASDAQ: NWBO) ("NW Bio"), a biotechnology company developing DCVax® personalized immune therapies
LOS ANGELES and MAASTRICHT, The Netherlands, March 19, 2015 /PRNewswire/ -- ImmunoCellular Therapeutics, Ltd.
- The act of burning, scorching, or heating to dryness; the state or being thus heated or dried.
- In medicine, cauterization.